NCT02853188 (FT-KBP) is a NA clinical trial of venous thromboembolism in Cancer of Lung, sponsored by Hopital Foch.

Who is sponsoring NCT02853188?

NCT02853188 is sponsored by Hopital Foch.

What drugs are being tested in NCT02853188?

Interventions in NCT02853188: venous thromboembolism.

What condition does NCT02853188 study?

NCT02853188 studies Cancer of Lung.

Is NCT02853188 still recruiting?

NCT02853188 is currently completed. Last updated 15 August 2019.

Last reviewed 2019-08-15 · How we verify

NCT02853188: FT-KBP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Measure of Plasma Tissue Factor to Predict a Venous Thromboembolism in Primitive Cancer of Lung

Completed NA Last updated 15 August 2019

What this trial tests

NA trial testing venous thromboembolism in Cancer of Lung in 315 participants. Completed in 20 December 2018.

Timeline

4 December 2014

Primary endpoint
20 December 2018

20 December 2018

Quick facts

Lead sponsor	Hopital Foch
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	315
Start date	4 December 2014
Primary completion	20 December 2018
Estimated completion	20 December 2018
Sites	5 locations across France

Drugs / interventions tested

venous thromboembolism

Conditions studied

Cancer of Lung — all drugs for Cancer of Lung →

Sponsor

Hopital Foch — full company profile →

Who can join

18 and older, any sex, with Cancer of Lung. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to evaluate if the plasma activity of the tissue factor at the time of the diagnosis of a lung cancer, before any treatment, or after the treatment of induction (surgery or two first cures of chemotherapy), can be a predictive factor of venous thromboembolism disease in the year which follows the diagnosis, independently of the other parameters.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Tissue factor as a new target for tumor therapy-killing two birds with one stone: a narrative review.
Li X, Cao D, Zheng X, Wang G, et al · · 2022 · cited 7× · PMID 36544632 · DOI 10.21037/atm-22-5067
Plasma tissue factor activity in lung cancer patients predicts venous thromboembolism and poor overall survival.
Doubre H, Monnet I, Azarian R, Girard P, et al · · 2024 · cited 4× · PMID 38666062 · DOI 10.1016/j.rpth.2024.102359

Verify or expand the search:

Other recruiting trials for Cancer of Lung

Currently open trials in the same condition.

NCT05857995 — Precision Lung Cancer Survivorship Care Intervention · NA · recruiting
NCT04699188 — Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation · Phase 1, PHASE2 · active not recruiting
NCT04263467 — High Intensity Aerobic Exercise Training and Immune Cell Mobilization in Patients With Lung Cancer (HI AIM) · NA · active not recruiting
NCT04300244 — Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma · Phase 2 · active not recruiting

Other Hopital Foch trials

Trials by the same sponsor.

NCT06980844 — Interpretation of the Role of Eosinophils in Diffuse Interstitial Pneumopathies · NA · not yet recruiting
NCT06757244 — DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer · Phase 2 · recruiting
NCT06631794 — Evaluation of the Impact of a HPV Vaccination Talk with Third Grade Students · not yet recruiting
NCT06533436 — Clinical and Economic Comparison of 2 Methods of Intubation Tube Fixation : AnchorFastTM Versus Current Cord Fixation · NA · recruiting
NCT06476002 — Analysis of the Understanding of the French Version of the Vulvar Pain Assessment Questionnaire · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02853188 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hopital Foch
Last refreshed: 15 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02853188.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing